165 related articles for article (PubMed ID: 2854659)
1. [Pentoxifylline and prostaglandins].
Poggesi L; Boddi M; Scarti L; Masotti G
Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
[No Abstract] [Full Text] [Related]
2. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
Weithmann KU; Just M; Schlotte V; Seiffge D
Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
[TBL] [Abstract][Full Text] [Related]
3. Reduced platelet aggregation by pentoxifylline stimulated prostacyclin release.
Weithmann KU
Vasa; 1981; 10(3):249-52. PubMed ID: 7025499
[No Abstract] [Full Text] [Related]
4. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
Chyzy R; Lukjan H; Rość D; Bielawiec M; Sawicka J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):549-54. PubMed ID: 2446996
[TBL] [Abstract][Full Text] [Related]
5. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
Weithmann KU
Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Strano A; Davì G; Novo S; Avellone G; Pinto A
Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
[No Abstract] [Full Text] [Related]
7. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
Matzky R; Darius H; Schrör K
Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacology and pharmacokinetics of pentoxifylline].
Mueller R
Ric Clin Lab; 1988; 18 Suppl 2():3-33. PubMed ID: 3073514
[No Abstract] [Full Text] [Related]
9. Drug stimulated prostacyclin release.
Weithmann KU
Ric Clin Lab; 1981; 11 Suppl 1():209-14. PubMed ID: 6324324
[TBL] [Abstract][Full Text] [Related]
10. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
Kostka-Trabkowa E; Dembińska-Kieć A; Grodzińska L; Bieroń K; Gryglewski RJ
Curr Med Res Opin; 1985; 9(6):407-15. PubMed ID: 3886306
[TBL] [Abstract][Full Text] [Related]
11. Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteers.
Pohanka E; Sinzinger H
Prostaglandins Leukot Med; 1986 May; 22(2):191-200. PubMed ID: 3523540
[TBL] [Abstract][Full Text] [Related]
12. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Manrique RV; Manrique V
Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
[TBL] [Abstract][Full Text] [Related]
13. Effect of pentoxifylline on platelet aggregation.
Nenci GG; Gresele P; Agnelli G; Ballatori E
Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of vascular diseases of the extremities using pentoxifylline].
Di Perri T
Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
[No Abstract] [Full Text] [Related]
16. Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.
Prisco D; Bartoletti A; Lombardi A
Int J Clin Pharmacol Res; 1984; 4(2):129-36. PubMed ID: 6147319
[TBL] [Abstract][Full Text] [Related]
17. [Effects of pentoxifylline and propentofylline on the turnover of polyphosphoinositides of the erythrocyte membrane and on the metabolism of arachidonic acid in platelets].
Rossignol L; Plantavid M; Chap H; Douste-Blazy L
Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1073-5. PubMed ID: 2851765
[TBL] [Abstract][Full Text] [Related]
18. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1979; 10(5):339-45. PubMed ID: 119023
[No Abstract] [Full Text] [Related]
19. Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
Gastpar H; Ambrus JL; Ambrus CM; Spavento P; Weber FJ; Thurber LE
J Med; 1977; 8(3-4):191-7. PubMed ID: 407320
[TBL] [Abstract][Full Text] [Related]
20. Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis.
Gordon S; Witul M; Cohen H; Sciandra J; Williams P; Gastpar H; Murphy GP; Ambrus JL
J Med; 1979; 10(6):435-43. PubMed ID: 233697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
